Cargando…
Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy
Type 1 diabetes (T1D) is an autoimmune disease that destroys pancreatic beta cells, which produce insulin in the islets of Langerhans. The risk of developing T1D is influenced by environmental factors, genetics, and autoantibodies. Latent autoimmune diabetes in adults (LADA) is a type of T1D that is...
Autores principales: | Siddiqui, Khalid, Nawaz, Shaik Sarfaraz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546931/ https://www.ncbi.nlm.nih.gov/pubmed/37795196 http://dx.doi.org/10.2147/ITT.S417917 |
Ejemplares similares
-
Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome
por: Nawaz, Shaik Sarfaraz, et al.
Publicado: (2022) -
Low Circulating Free Triiodothyronine Levels are Associated with the Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes
por: Siddiqui, Khalid, et al.
Publicado: (2022) -
Islet Autoantibodies to Pancreatic Insulin-Producing Beta Cells in Adolescent and Adults with Type 1 Diabetes Mellitus: A Cross-Sectional Study
por: Siddiqui, Khalid, et al.
Publicado: (2023) -
Risk Predictors of High Uric Acid Levels Among Patients with Type-2 Diabetes
por: Eljaaly, Zobeida, et al.
Publicado: (2021) -
Impact of Early Life or Intrauterine Factors and Socio-Economic Interaction on Diabetes - An Evidence on Thrifty Hypothesis
por: Siddiqui, Khalid, et al.
Publicado: (2019)